← All decks
The first 25 slides, exactly as they appear. The full deck has 101 content slides.
General Surgery
Perspective on Pancreatic Neoplasms (A)
Built from Maingot's Abdominal Operations

What’s inside
6 sections · 101 slides
Overview
- Scope of this perspective
- Anatomy of the pancreas that the argument rests on
- Exocrine and endocrine pancreas
- Why the topic has changed in one generation
Staging cancer of the pancreatic head
Reading the tumour-vessel relationship on CT, and deciding what to do first
- Purpose of preoperative staging
- Case for referral to a high-volume centre
- Endoscopic ultrasound-guided fine-needle biopsy of the pancreas
- Fine-needle aspiration cytology of pancreatic adenocarcinoma
- Arteries and veins that define resectability
- Celiac trunk and superior mesenteric artery around the pancreas
- Imaging features of early pancreatic ductal adenocarcinoma
- Pancreatic-region mass on contrast-enhanced abdominal CT
- Varadhachary CT-based classification
- Assumptions built into the Varadhachary definitions
- Varadhachary/Katz CT staging system for adenocarcinoma of the pancreatic head and uncinate process
- Reading the staging table
- Katz subtypes of borderline resectable disease
- Three forms of borderline resectable disease
- Type B: the biologic borderline patient
- Type C: the physiologic borderline patient
- What the Katz classification contributed
- AHPBA-SSO-SSAT consensus definition of resectable
- Two definitions of resectable compared
- Current consensus when surgery comes first
- Open questions in borderline resectable disease
- Regimens borrowed from metastatic disease
- Parts of the schedule that remain undefined
- ACOSOG Z5041 trial
Pancreaticoduodenectomy and local recurrence
The superior mesenteric artery dissection, and why the cancer comes back where it does
- Pancreaticoduodenectomy in outline
- Reconstruction after pancreaticoduodenectomy
- Exposing the superior mesenteric artery
- Pathophysiology of local recurrence
- How perineural spread produces local recurrence
- Consequence of better systemic therapy
Cystic neoplasms of the pancreas
Serous cystadenoma, mucinous cystic neoplasm and intraductal papillary mucinous neoplasm
- Three cystic neoplasms that dominate practice
- Growing importance of cystic lesions
- Large pancreatic cyst on abdominal CT
- Biology of serous cystadenoma
- Venous complications of serous cystadenoma
- Diagnosing serous cystadenoma
- Microcystic serous cystadenoma histology
- Role of EUS-guided aspiration in serous lesions
- Deciding on surgery for serous cystadenoma
- Observation policy for smaller serous lesions
- Diagnostic criterion for mucinous cystic neoplasm
- Mucinous cystic neoplasm with ovarian-type stroma
- Size and malignant potential in MCN
- Location of mucinous cystic neoplasms
- Worked example: a 3 cm mucinous lesion in the body
- Choice of operation for a body MCN
- Middle segment pancreatectomy as the preferred operation
- Sendai guidelines for intraductal papillary mucinous neoplasm
- Intraductal papillary mucinous neoplasm histology
- Rationale for observing low-risk IPMN
- Debate over enucleation and ablation in small IPMN
- Frozen-section assessment of the transection margin
- Limits of frozen-section expertise
- IPMN at the neck of the pancreas
- Margin planning in extended distal pancreatectomy
- Follow-up after resection for IPMN
Pancreatic neuroendocrine tumours
Biology that behaves quite unlike ductal cancer, and the operations it calls for
- Definition and nomenclature
- Pancreatic neuroendocrine tumour histology
- Behaviour of sporadic insulinoma
- Synchronous and metachronous metastases
- Size and metastatic risk in MEN1
- Observing small nonfunctioning pNETs in MEN1
- Zollinger-Ellison syndrome and the origin of gastrinoma
- Pancreatic gastrinoma
- Duodenal carcinoid tumours
- Well-differentiated neuroendocrine tumour of the duodenum
- Molecular origin of duodenal and pancreatic gastrinomas
- Causes of a raised serum gastrin level
- Distinguishing gastrinoma from parietal cell dysfunction
- Regional lymphadenectomy in neuroendocrine surgery
- Biochemical diagnosis of insulinoma
- The observed fast
- Interpreting the glucagon response
- Distribution of insulinoma within the pancreas
- Local recurrence after enucleation
- Technique of insulinoma enucleation
- Open versus laparoscopic enucleation
- Managing the pancreatic duct during enucleation
- Genetic testing and syndromic associations
- Timing surgery for MEN1 nonfunctional pNETs
- The Thompson procedure
- Completion total pancreatectomy in MEN1
- Targeted systemic therapy for metastatic pNETs
- Indolent metachronous recurrence and octreotide
- Multidisciplinary management of low-volume metastatic disease
- Selecting nonfunctioning pNETs for surgery
- Liver metastases: exocrine versus neuroendocrine
- Sequencing pancreas and liver surgery
- Portal vein embolization and staged hepatectomy
- Outlook for pancreatic neuroendocrine tumours
Take-home points
What to carry away from this perspective
- Take-home points on staging and sequencing
- Take-home points on cystic neoplasms
- Take-home points on neuroendocrine tumours
- References
- References (continued)
- References (continued)
- Maingot's Abdominal Operations, 12th Edition